Erik Jessen

606 total citations
28 papers, 373 citations indexed

About

Erik Jessen is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Erik Jessen has authored 28 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Erik Jessen's work include Multiple Myeloma Research and Treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Erik Jessen is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Erik Jessen collaborates with scholars based in United States, Australia and India. Erik Jessen's co-authors include Rachel A. Mooney, Jason M. Peters, Jeffrey A. Grass, Frances Tran, Robert Landick, Shaji Kumar, Dragan Jevremović, Taro Hitosugi, Surendra Dasari and Wilson I. Gonsalves and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Erik Jessen

25 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Jessen United States 8 269 162 75 61 42 28 373
Marc Hallier France 12 599 2.2× 183 1.1× 73 1.0× 23 0.4× 17 0.4× 16 663
Gareth King United Kingdom 7 481 1.8× 127 0.8× 56 0.7× 266 4.4× 40 1.0× 9 628
Jan Staelens Belgium 7 122 0.5× 87 0.5× 27 0.4× 46 0.8× 44 1.0× 11 351
Oscar L. Rodriguez United States 13 256 1.0× 104 0.6× 42 0.6× 27 0.4× 20 0.5× 29 552
Kathleen Martincic United States 11 519 1.9× 60 0.4× 137 1.8× 32 0.5× 28 0.7× 11 680
Sergey O. Sulima Belgium 11 633 2.4× 63 0.4× 24 0.3× 25 0.4× 108 2.6× 12 696
Christiane Dohet France 14 489 1.8× 102 0.6× 20 0.3× 27 0.4× 44 1.0× 16 552
Emily M. Gesner Canada 10 751 2.8× 54 0.3× 31 0.4× 182 3.0× 65 1.5× 14 811
Geneviève Pont-Kingdon United States 12 189 0.7× 94 0.6× 18 0.2× 51 0.8× 14 0.3× 22 347
Marcus R. Breese United States 7 257 1.0× 49 0.3× 19 0.3× 17 0.3× 41 1.0× 17 392

Countries citing papers authored by Erik Jessen

Since Specialization
Citations

This map shows the geographic impact of Erik Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jessen more than expected).

Fields of papers citing papers by Erik Jessen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jessen. The network helps show where Erik Jessen may publish in the future.

Co-authorship network of co-authors of Erik Jessen

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Jessen. A scholar is included among the top collaborators of Erik Jessen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Jessen. Erik Jessen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Raja, Remya, Kiran K. Mangalaparthi, Anil K. Madugundu, et al.. (2025). Immunogenic cryptic peptides dominate the antigenic landscape of ovarian cancer. Science Advances. 11(8). eads7405–eads7405. 3 indexed citations
3.
Bernard, Cheryl E., Erik Jessen, Vernadette Simon, et al.. (2024). Protocol for isolating immune cells from human gastric muscularis propria for single-cell analysis. STAR Protocols. 5(3). 103258–103258. 1 indexed citations
4.
O’Brien, Daniel R., Erik Jessen, Cecília Bonolo de Campos, et al.. (2024). Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers. 16(13). 2450–2450. 2 indexed citations
5.
Weaver, Samantha, et al.. (2024). Phlpp1 alters the murine chondrocyte phospho-proteome during endochondral bone formation. Bone. 189. 117265–117265.
6.
Wickland, Daniel P., Erik Jessen, Brian M. Necela, et al.. (2024). Comprehensive profiling of cancer neoantigens from aberrant RNA splicing. Journal for ImmunoTherapy of Cancer. 12(5). e008988–e008988. 4 indexed citations
7.
Guicciardi, Maria Eugenia, Erik Jessen, Jingchun Yang, et al.. (2024). IL-17 signaling in primary sclerosing cholangitis patient-derived organoids. Hepatology Communications. 8(6). 7 indexed citations
8.
Yonkus, Jennifer A., Amro M. Abdelrahman, Caitlin B. Conboy, et al.. (2024). YAPTEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape. FEBS Open Bio. 14(11). 1873–1887. 1 indexed citations
9.
Norton, Emily S., Mieu Brooks, Erik Jessen, et al.. (2024). Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone. Science Advances. 10(32). eadn1607–eadn1607. 4 indexed citations
10.
Baughn, Linda B., Erik Jessen, Neeraj Sharma, et al.. (2023). Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma. Blood Cancer Journal. 13(1). 84–84. 4 indexed citations
11.
Jessen, Erik, Bharat Nandakumar, Dragan Jevremović, et al.. (2022). Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma. American Journal of Hematology. 97(7). 895–902. 8 indexed citations
12.
Jessen, Erik, Yuanhang Liu, Jaime Davila, Jean-Pierre A. Kocher, & Chen Wang. (2021). Determining mutational burden and signature using RNA-seq from tumor-only samples. BMC Medical Genomics. 14(1). 65–65. 9 indexed citations
13.
Boland, Jennifer M., Hee Eun Lee, Emily G. Barr Fritcher, et al.. (2020). Molecular Genetic Landscape of Sclerosing Pneumocytomas. American Journal of Clinical Pathology. 155(3). 397–404. 7 indexed citations
14.
Gonsalves, Wilson I., Jin Sung Jang, Erik Jessen, et al.. (2020). In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells. SHILAP Revista de lepidopterología. 8(1). 29–29. 22 indexed citations
15.
Gonsalves, Wilson I., Katarzyna A. Broniowska, Erik Jessen, et al.. (2020). Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma. Scientific Reports. 10(1). 10250–10250. 23 indexed citations
16.
Mounajjed, Taofic, Roger K. Moreira, Daniela Allende, et al.. (2020). Transcriptomic and Proteomic Analysis of Steatohepatitic Hepatocellular Carcinoma Reveals Novel Distinct Biologic Features. American Journal of Clinical Pathology. 155(1). 87–96. 9 indexed citations
17.
Macke, Erica L., Erik Jessen, Nicholas A. Zumwalde, et al.. (2019). Loss of Chondroitin Sulfate Modification Causes Inflammation and Neurodegeneration in skt Mice. Genetics. 214(1). 121–134. 16 indexed citations
18.
Kourelis, Taxiarchis, José C. Villasboas, Erik Jessen, et al.. (2019). Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies. Blood Cancer Journal. 9(9). 72–72. 27 indexed citations
19.
Jessen, Erik, et al.. (2014). Serum response factor: positive and negative regulation of an epithelial gene expression network in the destrin mutant cornea. Physiological Genomics. 46(8). 277–289. 6 indexed citations
20.
Peters, Jason M., Rachel A. Mooney, Jeffrey A. Grass, et al.. (2012). Rho and NusG suppress pervasive antisense transcription in Escherichia coli. Genes & Development. 26(23). 2621–2633. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026